Medication for Alleviating Parkinson's Symptoms and Method of Administering

Abstract

A drug and method of administering it to temporarily moderate the symptoms of neurological degenerative diseases such as Parkinson's. The drug is mixed in a liquid form with a nasal atomizer and administered twice a day by introduction as an atomized liquid into the nasal cavity. It provides instantaneous moderation of tremors, internal uneasyiness, limb rigidity, gait and balance problems, memory loss, slurred speech and verbal trailing off. The results last approximately three to four hours. The dosage is dependent on the weight of the patient and is given upon rising in the morning and at bed time.

1 . A medication for the temporary relief of neurological degenerative diseases, comprising:
 a homogeneous solution made of:   one part by volume dimethyl sulfoxide (DMSO);   30 parts by volume anhydrous chloride (HOCl); and   wherein said DMSO is 70% concentrated DMSO; and   wherein said HOCl is a 0.02 to 0.035% stabilized, equilibrium concentration of Hypochlorous acid in electrolyzed water.   
     
     
         2 . The medication for the temporary relief of neurological degenerative diseases of  claim 1 , wherein said homogeneous solution further comprises:
 28 parts by volume normalized saline solution, wherein said normalized saline solution is electrolyzed water with a 0.5 to 1.5 percent by weight NaCl concentration.   
     
     
         3 . The medication of  claim 2 , further comprising;
 a nasal spray delivery means housing said homogeneous solution, said nasal delivery means selected from the set of nasal spray delivery means including nasal spray pumps, nasal spray squeeze containers, nasal bulb sprayers, nasal spray atomizers, nebulizers and spray atomizers, wherein said nasal deliver means is made of materials non soluble in DMSO.   
     
     
         4 . The medication for the temporary relief of neurological degenerative diseases of  claim 3  wherein;
 said DMSO is 99.9% pure that has been mixed to a 70% concentration with distilled water, and 
 wherein said Hypochlorous acid is of a 0.02 to 0.035% concentration, made of more than 97.796% electrolyzed H 2 O and 1.7 to 2.2% NaCl. 
 
     
     
         5 . A method of for the temporary treatment of a patient with a neurological degenerative disease, comprising the steps of:
 mixing a homogeneous solution of 1 part dimethylsulfioxide (DMSO) mixed to 70% concentration with distilled water, 30 parts electrolyzed anhydrous chloride (HOCl) of a 0.02 to 0.035% concentration, made of more than 97.796% electrolyzed H 2 O and 1.7 to 2.2% NaCl, and 28 parts normalized saline solution having a concentration of 0.7-0.9 percent NaCl with distilled water;   putting said homogeneous solution into a nasal spray delivery means that is made of materials that are not soluble in DMSO;   administering at least one atomized dose of said homogeneous solution of approximately 0.4 ml into each nasal cavity of a patient.   
     
     
         6 . The method of  claim 5  wherein the number of atomized doses administered to said patient is two when said patient is over 120 lbs in weight, and one when the patient is less than 120 lbs in weight. 
     
     
         7 . The Method of  claim 5  wherein said homogeneous solution is administered twice a day, once upon rising and once prior to sleep.